Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-008381
Filing Date
2025-05-02
Accepted
2025-05-02 16:38:56
Documents
1
Period of Report
2025-04-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2186
  Complete submission text file 0001641172-25-008381.txt   3798
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 41 THE WILLOW APARTMENT DROGHEDA CO LOUTH L2 Ireland A92VR7
Business Address
Laurduraj Inigo Angel (Reporting) CIK: 0002065893 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25909315